{"filing":{"accession_number":"0001171843-26-005728","cik":"0001421876","ticker":"GLPG","company_name":"Lakefront Biotherapeutics NV","form":"6-K","filing_date":"2026-08-25","report_date":"2026-08-25","primary_document":"f6k_082526.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1421876/000117184326005728/f6k_082526.htm"},"events":[{"id":29380,"run_id":26898,"accession_number":"0001171843-26-005728","anchor_item_number":"EX-99.1","event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.85,"summary":"Bank of America Corporation crossed the 10% voting-rights threshold in Lakefront Biotherapeutics on August 18, 2026, triggering a mandatory transparency notification under Belgian law. The disclosure reports that BofA holds 2.15% direct voting rights and 7.96% in equivalent financial instruments (swaps, rights of use, rights to recall), totaling 10.11% of outstanding shares. This is a material governance event affecting shareholder composition and potential control dynamics, though it does not fit the specific categories of exec_appointment, exec_departure, or shareholder_vote_results; governance_other is the appropriate classification for a material threshold-crossing notification.","company_name":"Lakefront Biotherapeutics NV","ticker":"GLPG","filing_date":"2026-08-25","form":"6-K","submitted_at":null,"items":[{"id":31641,"accession_number":"0001171843-26-005728","item_number":"EX-99.1","item_title":"exh_991.htm","event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"Bank of America Corporation crossed the 10% voting-rights threshold in Lakefront Biotherapeutics on August 18, 2026, triggering a mandatory transparency notification under Belgian law. The disclosure reports that BofA holds 2.15% direct voting rights and 7.96% in equivalent financial instruments (swaps, rights of use, rights to recall), totaling 10.11% of outstanding shares. This is a material governance event affecting shareholder composition and potential control dynamics, though it does not fit the specific categories of exec_appointment, exec_departure, or shareholder_vote_results; governance_other is the appropriate classification for a material threshold-crossing notification.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-08-25T14:26:38.217670+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":31641,"accession_number":"0001171843-26-005728","item_number":"EX-99.1","item_title":"exh_991.htm","event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"Bank of America Corporation crossed the 10% voting-rights threshold in Lakefront Biotherapeutics on August 18, 2026, triggering a mandatory transparency notification under Belgian law. The disclosure reports that BofA holds 2.15% direct voting rights and 7.96% in equivalent financial instruments (swaps, rights of use, rights to recall), totaling 10.11% of outstanding shares. This is a material governance event affecting shareholder composition and potential control dynamics, though it does not fit the specific categories of exec_appointment, exec_departure, or shareholder_vote_results; governance_other is the appropriate classification for a material threshold-crossing notification.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-08-25T14:26:38.217670+00:00","company_name":"Lakefront Biotherapeutics NV","ticker":"GLPG","filing_date":"2026-08-25"}]}